Clinical Trials on Toxemia in Australia

Total 22 results

The University of Queensland
Royal Brisbane and Women's Hospital

Unknown

Exercise in Critically Ill Patients With Sepsis

Sepsis Syndromes

Australia
The George Institute for Global Health, Australia

Completed

Days Alive and Out of Hospital for Patients With Sepsis

Sepsis | Septic Shock

Australia
Medical University of Graz

Completed

Modulation of Gut Microbiota in Early Sepsis: A Pilot Study (MGM-sepsis)

Sepsis

Austria
Belinda Howe
Australian and New Zealand Intensive Care Society Clinical Trials Group; Australasian...

Unknown

Australasian Resuscitation In Sepsis Evaluation Randomised Controlled Trial (ARISE)

Severe Sepsis

New Zealand, Australia, Finland, Ireland, Hong Kong
University of British Columbia
Canadian Institutes of Health Research (CIHR)

Active, not recruiting

New Strategy to Predict Early Sepsis

Sepsis

Australia, Netherlands, United States, Canada, Colombia
Medical University of Vienna

Completed

Anti-Inflammatory Effect of Statins in the Human Endotoxin Model

Endotoxemia

Austria
Medical University of Vienna

Completed

Ethnic Differences in the Inflammatory Response in Systemic Inflammation

Endotoxemia

Austria
University of Vienna

Recruiting

Different Dietary Patterns

Endotoxemia | Diet, Healthy

Austria
Medical University of Vienna

Completed

Vorapaxar in the Human Endotoxemia Model

Healthy Volunteers

Austria
University of Vienna

Completed

Effects of Non-calorie Sweeteners, Mono- and Disaccharides on Intestinal Barrier Function

Endotoxemia | Dietary Habits

Austria
University of Vienna

Completed

Cereals and Intestinal Function

Endotoxemia | Diet, Healthy

Austria
Bernd Jilma

Completed

Defibrotide in the Human Endotoxemia Model --- an Exploratory Trial Investigating the Effects and the Mechanisms of Defibrotide (LPS_DF)

Endotoxemia | Healthy Volunteers

Austria
Green Beat

Completed

Probiotic Sport Study

Inflammation | Endotoxemia | Oxidative Stress

Austria
Austin Health

Completed

Super High-Flux - High Volume Dialysis in Sepsis-Induced Acute Renal Failure

Sepsis | Acute Renal Failure

Australia
Medical University Innsbruck

Completed

Influence of Cytosorb on Amount of Catecholamine and Mortality in Sepsis

Sepsis | Septic Shock | Cytokine Storm | Cytokine Release Syndrome | Catecholamine

Austria
Eli Lilly and Company

Completed

The Study of Drotrecogin Alfa (Activated) in Adult Patients With Severe Sepsis at a Low Risk of Death

Sepsis

Canada, Finland, Belgium, Argentina, Chile, Australia, Austria, Brazil, Czech Republic, Denmark, Egypt, France
AstraZeneca

Completed

A Study to Compare the Efficacy and Safety of 2 Dosing Regimens of IV Infusions of AZD9773 (CytoFab™) With Placebo in Adult Patients With Severe Sepsis and/or Septic Shock

Septic Shock | Severe Sepsis

Czech Republic, France, Spain, Finland, Canada, Australia, Belgium
Eli Lilly and Company

Completed

Investigation of the Efficacy and Safety of Drotrecogin Alfa (Activated) in Pediatric Severe Sepsis

Sepsis

United States, United Kingdom, France, Slovakia, Switzerland, Australia, Poland, Italy, Chile, Germany, Mexico
Eisai Inc.

Completed

ACCESS: A Controlled Comparison of Eritoran Tetrasodium and Placebo in Patients With Severe Sepsis

Severe Sepsis

United States, France, Poland, United Kingdom, Germany, Hong Kong, Taiwan, Spain, Switzerland, Argentina, Belgium, Israel, South Africa, Japan, Canada, Netherlands, Korea, Republic of, Australia, Chile, Brazil, Austria, Italy, Czechia, Portug...
GlaxoSmithKline

Completed

GR270773 In The Treatment Of Suspected Or Confirmed Gram-Negative Severe Sepsis In Adults

Sepsis

United States, Canada, France, Netherlands, Russian Federation, Taiwan, Czechia, Estonia, Spain, Sweden, Thailand, Germany, Belgium, Israel, United Kingdom, Korea, Republic of, Portugal, Finland, Latvia, New Zealand, Malaysia, South... and more
Takeda

Completed

Efficacy & Safety of Resatorvid in Adults With Severe Sepsis

Sepsis

United States, United Kingdom, Belgium, Germany, Spain, Israel, Japan, Australia, Canada, Finland, Netherlands, New Zealand, Czech Republic, Puerto Rico, Austria, Sweden, Italy
Asahi Kasei Pharma America Corporation

Completed

Phase 3 Safety and Efficacy Study of ART-123 in Subjects With Severe Sepsis and Coagulopathy

Severe Sepsis | Coagulopathy

Korea, Republic of, United States, Taiwan, Netherlands, United Kingdom, Australia, Canada, Belgium, Israel, Spain, New Zealand, France, Brazil, India, Argentina, Bulgaria, Croatia, Czechia, Finland, Germany, Hungary, Peru, Russian Federation and more

Clinical Trials on Toxemia in Australia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Papua New Guinea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations